Founder Evidente. Top rated quantitative analyst, Evidente

Sam Ferraro

Founder Evidente. Top rated quantitative analyst

Evidente

Evidente is an independent financial education firm that delivers innovative financial advice to wholesale investors, including active long only funds, hedge funds, pension funds, and sovereign wealth funds, in Australia and globally.  Drawing on academic research in asset pricing, behavioural finance and portfolio construction, Evidente provides wholesale investors with commercial solutions to stock selection and asset allocation decisions across equities and other asset classes.

Thematic (Sector/Industry)

Data released by the Australian Bureau of Statistics today showed that new motor vehicle registrations fell sharply in the month of October by 3.6%, representing the largest monthly decline since December 2011.  But this follows a 5.9% rise in September, the largest monthly gain since December 2011.Looking through the elevated volatility of the series of recent months, the trend remains robust.  New motor vehicle registrations are 4.2% higher than a year ago and remain close to a record high…

Data released by the Australian Bureau of Statistics today showed that new motor vehicle registrations fell sharply in the month of October by 3.6%, representing the largest monthly decline since December 2011.  But this follows a 5.9% rise in September, the largest monthly gain since December 2011.Looking through the elevated volatility of the series of recent months, the trend remains robust.  New motor vehicle registrations are 4.2% higher than a year ago and remain close to a record high…

Australian New Motor Vehicle Registrations Pull Back in October, but the Trend Remains Robust

<ul><li>A number of developments in the past week were a stark reminder that&nbsp;Australia&rsquo;s exports to China&nbsp;are undergoing a revolution thanks to inexorable&nbsp;rise of China's middle class.&nbsp;&nbsp;At a time when BHP dropped to a decade low, the news-flow in Australia focussed on &nbsp;the growing shortage on supermarket shelves of Bellamy&rsquo;s baby formula, while overseas arrivals from China continue to surge.&nbsp;</li><li>Chinese demand for&nbsp;Australia's agri-food products, vitamins, wine, tourism, higher education and other non-commodity goods and&nbsp;services&nbsp;will continue to grow strongly and help diversify our export basket.&nbsp; In an environment where the aggregate supply of growth in Australia is low, the rise of China's middle class is a powerful and seductive investment theme that offers strong growth prospects to Australia's non-commodity exporters.</li><li>The key macro announcement in Australia in the past week was the stronger than expected employment print for the month of October.&nbsp; Expectations of a December rate cut have consequently diminished.&nbsp; Evidente has been of the view that given the spare capacity in the economy and labour market, the RBA should deliver more monetary stimulus.&nbsp; One strong monthly employment outcome is not sufficient to alter my view that labour market conditions are slack and that another rate cut is necessary.</li></ul>

A number of developments in the past week were a stark reminder that&nbsp;Australia&rsquo;s exports to China&nbsp;are undergoing a revolution thanks to inexorable&nbsp;rise of China's middle class.&nbsp;&nbsp;At a time when BHP dropped to a decade low, the news-flow in Australia focussed on &nbsp;the growing shortage on supermarket shelves of Bellamy&rsquo;s baby formula, while overseas arrivals from China continue to surge.&nbsp;Chinese demand for&nbsp;Australia's agri-food products, vitamins, wine, tourism, higher education and other non-commodity goods and&nbsp;services&nbsp;will continue to grow strongly and help diversify our export basket.&nbsp; In an environment where the aggregate supply of growth in Australia is low, the rise of China's middle class is a powerful and seductive investment theme that offers strong growth prospects to Australia's non-commodity exporters.The key macro announcement in Australia in the past week was the stronger than expected employment print for the month of October.&nbsp; Expectations of a December rate cut have consequently diminished.&nbsp; Evidente has been of the view that given the spare capacity in the economy and labour market, the RBA should deliver more monetary stimulus.&nbsp; One strong monthly employment outcome is not sufficient to alter my view that labour market conditions are slack and that another rate cut is necessary.

Weekly Impressions - Australia's Export Revolution to China's Rising Middle Class

<ul><li>This post provides an update of Evidente&rsquo;s currency model.&nbsp; Under-valuation of the A$/US$ has now reached an extreme, while the Big Mac index also points to deep A$/US$ under-valuation.&nbsp; ASX listed US$ earners have performed poorly despite the renewed deprecation of the A$ over the past six months.&nbsp;</li><li>I also assess the investment case against Brambles, which generates around half of its revenue in North America.&nbsp; The company will be undergoing a capex hump at a time when its marginal return on capital has been deteriorating to the point of recently turning negative.&nbsp;</li><li>I examine its remuneration scheme and conclude that the fact that the board, ESG advisory firms and institutional investors endorse complex and opaque Long Term Incentive plans of this kind, suggests that the bloated corporate governance industry has a long way to go to achieving adequate alignment of interests between senior executives and shareholders.</li></ul>

This post provides an update of Evidente&rsquo;s currency model.&nbsp; Under-valuation of the A$/US$ has now reached an extreme, while the Big Mac index also points to deep A$/US$ under-valuation.&nbsp; ASX listed US$ earners have performed poorly despite the renewed deprecation of the A$ over the past six months.&nbsp;I also assess the investment case against Brambles, which generates around half of its revenue in North America.&nbsp; The company will be undergoing a capex hump at a time when its marginal return on capital has been deteriorating to the point of recently turning negative.&nbsp;I examine its remuneration scheme and conclude that the fact that the board, ESG advisory firms and institutional investors endorse complex and opaque Long Term Incentive plans of this kind, suggests that the bloated corporate governance industry has a long way to go to achieving adequate alignment of interests between senior executives and shareholders.

A$ buy signal strengthens | Investment case against Brambles

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Kalon is unlikely to overbid KKR for <a href="https://www.smartkarma.com/entities/mandom-corp" target="_blank" data-smartkarma-citation="entities:8353:1" rel="noopener">Mandom (4917 JP)</a>. KKR is unlikely to walk despite the earnings guidance revision after the DD.  ¥3,100+ is a fine place to sell.</li>
<li>Panama’s Supreme Court dings <a href="https://www.smartkarma.com/entities/ck-hutchison-holdings-ltd" target="_blank" data-smartkarma-citation="entities:132:1" rel="noopener">CK Hutchison (1 HK)</a>'s port concessions. CKH/Beijing won't go down without a fight; and rejigging a deal for the remaining ports will (likely) be perennially delayed.</li>
<li>
<a href="https://www.smartkarma.com/entities/hisamitsu-pharmaceutical-co" target="_blank" data-smartkarma-citation="entities:17008:1" rel="noopener">Hisamitsu Pharmaceutical Co (4530 JP)</a>is trading through terms. The family Tender Offer is light, but it likely has enormous crossholder support. They could still claim majority of minority.</li>
</ul>


Kalon is unlikely to overbid KKR for Mandom (4917 JP). KKR is unlikely to walk despite the earnings guidance revision after the DD.  ¥3,100+ is a fine place to sell.
Panama’s Supreme Court dings CK Hutchison (1 HK)'s port concessions. CKH/Beijing won't go down without a fight; and rejigging a deal for the remaining ports will (likely) be perennially delayed.

Hisamitsu Pharmaceutical Co (4530 JP)is trading through terms. The family Tender Offer is light, but it likely has enormous crossholder support. They could still claim majority of minority.


Last Week In Event SPACE: CK Hutchison, Hisamitsu Pharma, JCNC, Mandom, Sunny Optical, Rio

Hisamitsu Pharmaceutical Co / Event-Driven

<ul>
<li>I tally 35 - mostly firm, mostly Asia-Pac - arb transactions currently being discussed and analysed on Smartkarma. Those arbs metrics and upcoming events are detailed below.</li>
<li>No new deals were discussed on Smartkarma this week - kinda surprising.</li>
<li>Key updates/news also took place on: <a href="https://www.smartkarma.com/entities/bluescope-steel-ltd" target="_blank" data-smartkarma-citation="entities:207:1" rel="noopener">Bluescope Steel (BSL AU)</a>, <a href="https://www.smartkarma.com/entities/iress-ltd" target="_blank" data-smartkarma-citation="entities:15342:1" rel="noopener">Iress  (IRE AU)</a>, <a href="https://www.smartkarma.com/entities/skyworth-group-limited" target="_blank" data-smartkarma-citation="entities:10941:1" rel="noopener">Skyworth Group (751 HK)</a>, <a href="https://www.smartkarma.com/entities/toyota-industries-corp" target="_blank" data-smartkarma-citation="entities:4500:1" rel="noopener">Toyota Industries (6201 JP)</a>, <a href="https://www.smartkarma.com/entities/raksul-inc" target="_blank" data-smartkarma-citation="entities:27043:1" rel="noopener">Raksul Inc (4384 JP)</a>, and <a href="https://www.smartkarma.com/entities/sankei-real-estate-inc" target="_blank" data-smartkarma-citation="entities:35239:1" rel="noopener">Sankei Real Estate (2972 JP)</a>.
</li>
</ul>


I tally 35 - mostly firm, mostly Asia-Pac - arb transactions currently being discussed and analysed on Smartkarma. Those arbs metrics and upcoming events are detailed below.
No new deals were discussed on Smartkarma this week - kinda surprising.
Key updates/news also took place on: Bluescope Steel (BSL AU), Iress  (IRE AU), Skyworth Group (751 HK), Toyota Industries (6201 JP), Raksul Inc (4384 JP), and Sankei Real Estate (2972 JP).



Asia-Pac M&A Weekly Wrap: Bluescope Steel, Iress, Skyworth, Toyota Inds., Raksul, Sankei Real Estate

Australia

FleetPartners Group Limited provides vehicle fleet leasing, fleet management, and diversified financial services. The Company offers consumers and businesses access to funding solutions including fleet leasing, vehicle sales, commercial equipment finance, and consumer motor vehicle finance. FleetPartners Group serves customers in Australia and New Zealand.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

FleetPartners Group (FPR AU)

Australian New Motor Vehicle Registrations Pull Back in October, but the Trend Remains Robust

Data released by the Australian Bureau of Statistics today showed that new motor vehicle registrations fell sharply in the month of October by...

Sam Ferraro

Weekly Impressions - Australia's Export Revolution to China's Rising Middle Class

A number of developments in the past week were a stark reminder that Australia’s exports to China are undergoing a revolution thanks to...

Sam Ferraro

A$ buy signal strengthens | Investment case against Brambles

This post provides an update of Evidente’s currency model. Under-valuation of the A$/US$ has now reached an extreme, while the Big Mac index also...

Sam Ferraro

Last Week In Event SPACE: CK Hutchison, Hisamitsu Pharma, JCNC, Mandom, Sunny Optical, Rio

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

David Blennerhassett

Asia-Pac M&A Weekly Wrap: Bluescope Steel, Iress, Skyworth, Toyota Inds., Raksul, Sankei Real Estate

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)